Macrophage phenotypic plasticity in atherosclerosis: The associated features and the peculiarities of the expression of inflammatory genes

International Journal of Cardiology

Volumn 184, Issue 1, 2015, Pages 436-445

  Chistiakov, Dimitry A ^a   Bobryshev, Yuri V ^b,c,d   Nikiforov, Nikita G ^d,e   Elizova, Natalia V ^d,e   Sobenin, Igor A ^d,e,f   Orekhov, Alexander N ^e,f,g  

^a PIROGOV RUSSIAN NATIONAL RESEARCH MEDICAL UNIVERSITY   (Russian Federation)

^b UNIVERSITY OF NEW SOUTH WALES   (Australia)

^c UNIVERSITY OF WESTERN SYDNEY   (Australia)

^d INSTITUTE OF GENERAL PATHOLOGY AND PATHOPHYSIOLOGY   (Russian Federation)

^e Institute for Atherosclerosis Research   (Russian Federation)

^f INSTITUTE OF EXPERIMENTAL CARDIOLOGY   (Russian Federation)

^g MOSCOW STATE UNIVERSITY   (Russian Federation)

Author keywords

Atherogenesis; Atherosclerosis; Heterogeneity; Inflammation; Macrophages; Plasticity

Indexed keywords

ABC TRANSPORTER A1; ABC TRANSPORTER G1; APOLIPOPROTEIN E; CALGRANULIN A; CD163 ANTIGEN; COLONY STIMULATING FACTOR 1; CXCL11 CHEMOKINE; CXCL9 CHEMOKINE; GAMMA INTERFERON; GAMMA INTERFERON INDUCIBLE PROTEIN 10; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INDUCIBLE NITRIC OXIDE SYNTHASE; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 1BETA; INTERLEUKIN 23; INTERLEUKIN 6; LIVER X RECEPTOR ALPHA; MACROPHAGE DERIVED CHEMOKINE; MACROPHAGE ELASTASE; MESSENGER RNA; OXIDIZED LOW DENSITY LIPOPROTEIN; REACTIVE OXYGEN METABOLITE; THYMUS AND ACTIVATION REGULATED CHEMOKINE; TOLL LIKE RECEPTOR; TRANSCRIPTION FACTOR; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR ALPHA; CYTOKINE;

ABCA 1 GENE; ABCG1 GENE; APOE GENE; ARTICLE; ATHEROGENESIS; ATHEROSCLEROSIS; ATHEROSCLEROTIC PLAQUE; CCL2 GENE; CELL POLARITY; CYTOKINE RESPONSE; GENE EXPRESSION; GENE EXPRESSION REGULATION; HUMAN; IMMUNOMODULATION; INFLAMMATION; INNATE IMMUNITY; LXR ALPHA GENE; MACROPHAGE; MACROPHAGE FUNCTION; MMP 9 GENE; MOUSE MODEL; NFKAPPAB GENE; NONHUMAN; PHENOTYPIC PLASTICITY; PRIORITY JOURNAL; TNF ALPHA GENE; TRANSCRIPTION REGULATION; ANIMAL; CELL PLASTICITY; DISEASE COURSE; GENETICS; GENOME-WIDE ASSOCIATION STUDY; IMMUNOLOGY; MACROPHAGE ACTIVATION; METABOLISM; MOUSE; PATHOPHYSIOLOGY; PHENOTYPE; PHYSIOLOGY;

ANIMALS; ATHEROSCLEROSIS; CELL PLASTICITY; CYTOKINES; DISEASE PROGRESSION; GENE EXPRESSION REGULATION; GENOME-WIDE ASSOCIATION STUDY; HUMANS; INFLAMMATION; MACROPHAGE ACTIVATION; MACROPHAGES; MICE; PHENOTYPE; PLAQUE, ATHEROSCLEROTIC; TRANSCRIPTION FACTORS;

EID: 84929947217     PISSN: 01675273     EISSN: 18741754     Source Type: Journal    
DOI: 10.1016/j.ijcard.2015.03.055     Document Type: Review

References (129)

1. R. Ross, Atherosclerosis - An inflammatory disease, N. Engl. J.Med. 340 (2) (Jan 14 1999) 115-126.
2. G.K. Hansson, Inflammation, atherosclerosis, and coronary artery disease, N. Engl. J. Med. 352 (2005) 1685-1695.
3. P. Libby, P.M. Ridker, G.K. Hansson, Leducq Transatlantic Network on Atherothrombosis. Inflammation in atherosclerosis: from pathophysiology to practice, J. Am. Coll. Cardiol. 54 (2009) 2129-2138.
4. H.C. Stary, A.B. Chandler, S. Glagov, J.R. Guyton, W. Insull Jr., M.E. Rosenfeld, S.A. Schaffer, C.J. Schwartz, W.D. Wagner, R.W. Wissler, A definition of initial, fatty streak, and intermediate lesions of atherosclerosis. A report from the Committee on Vascular Lesions of the Council on Arteriosclerosis, American Heart Association, Circulation 89 (1994) 2462-2478.
5. H.C. Stary, A.B. Chandler, R.E. Dinsmore, V. Fuster, S. Glagov, W. Insull Jr., M.E. Rosenfeld, C.J. Schwartz, W.D. Wagner, R.W. Wissler, A definition of advanced types of atherosclerotic lesions and a histological classification of atherosclerosis. A report from the Committee on Vascular Lesions of the Council on Arteriosclerosis, American Heart Association, Circulation 92 (1995) 1355-1374.
6. R.G. Gerrity, The role of the monocyte in atherogenesis. I. Transition of blood-borne monocytes into foam cells in fatty lesions, Am. J. Pathol. 103 (1981) 181-190.
7. V.R. Babaev, Y.V. Bobryshev, G.K. Sukhova, I.A. Kasantseva, Monocyte/macrophage accumulation and smooth muscle cell phenotypes in early atherosclerotic lesions of human aorta, Atherosclerosis 100 (1993) 237-248.
8. K. Ley, Y.I. Miller, C.C. Hedrick, Monocyte and macrophage dynamics during atherogenesis, Arterioscler. Thromb. Vasc. Biol. 31 (2011) 1506-1516.
9. A.N. Orekhov, Y.V. Bobryshev, I.A. Sobenin, A.A.Melnichenko, D.A. Chistiakov, Modified low density lipoprotein and lipoprotein-containing circulating immune complexes as diagnostic and prognostic biomarkers of atherosclerosis and type 1 diabetes macrovascular disease, Int. J. Mol. Sci. 15 (2014) 12807-12841.
10. Y.V. Bobryshev, T.A. Shchelkunova, I.A. Morozov, P.M. Rubtsov, I.A. Sobenin, A.N. Orekhov, A.N. Smirnov, Changes of lysosomes in the earliest stages of the development of atherosclerosis, J. Cell. Mol. Med. 17 (2013) 626-635.
11. Y.V. Bobryshev, Monocyte recruitment and foam cell formation in atherosclerosis, Micron 37 (2006) 208-222.
12. M.W. Freeman, Macrophage scavenger receptors, Curr. Opin. Lipidol. 5 (1994) 143-148.
13. H.S. Kruth, Macrophage foam cells and atherosclerosis, Front. Biosci. 6 (2001) D429-D455.
14. H.S. Kruth, Fluid-phase pinocytosis of LDL by macrophages: A novel target to reduce macrophage cholesterol accumulation in atherosclerotic lesions, Curr. Pharm. Des. 19 (2013) 5865-5872.
15. G.J. Randolph, Mechanisms that regulate macrophage burden in atherosclerosis, Circ. Res. 114 (2014) 1757-1771.
16. K.J. Moore, I. Tabas, Macrophages in the pathogenesis of atherosclerosis, Cell 145 (2011) 341-355.
17. Y.V. Bobryshev, M.M. Moisenovich, O.L. Pustovalova, I.I. Agapov, A.N. Orekhov, Widespread distribution of HLA-DR-expressing cells in macroscopically undiseased intima of the human aorta: A possible role in surveillance and maintenance of vascular homeostasis, Immunobiology 217 (2012) 558-568.
18. C. De Duve, The significance of lysosomes in pathology and medicine, Proc. Inst. Med. Chic. 26 (1966) 73-76.
19. C. De Duve, The role of lysosomes in cellular pathology, Triangle 9 (1970) 200-208.
20. T. Seimon, I. Tabas, Mechanisms and consequences of macrophage apoptosis in atherosclerosis, J. Lipid Res. 50 (2009) S382-S387 (Suppl.).
21. A. Melián, Y.J. Geng, G.K. Sukhova, P. Libby, S.A. Porcelli, CD1 expression in human atherosclerosis, Am. J. Pathol. 155 (1999) 775-789.
22. Y.V. Bobryshev, R.S. Lord, Y.J. Geng, CD1 Expression and the nature of CD1-expressing cells in human atherosclerotic plaques, Am. J. Pathol. 156 (2000) 1477-1478.
23. L.H. Shen, L. Zhou, B.Y. Wang, J. Pu, L.H. Hu, D.J. Chai, L. Wang, J.Z. Zeng, B. He, Oxidized low-density lipoprotein induces differentiation of RAW264.7murinemacrophage cell line into dendritic-like cells, Atherosclerosis 199 (2008) 257-264.
24. F. Porcheray, S. Viaud, A.C. Rimaniol, C. Leone, B. Samah, N. Dereuddre-Bosquet, D. Dormont, G. Gras, Macrophage activation switching: An asset for the resolution of inflammation, Clin. Exp. Immunol. 142 (2005) 481-489.
25. N. Leitinger, I.G. Schulman, Phenotypic polarization of macrophages in atherosclerosis, Arterioscler. Thromb. Vasc. Biol. 33 (2013) 1120-1126.
26. N.A.Nicola, D.Metcalf, Specificity of action of colony-stimulating factors in the differentiation of granulocytes and macrophages, Ciba Found. Symp. 118 (1986) 7-28.
27. S. Zhang, C.C. Kim, S. Batra, J.H. McKerrow, P. Loke, Delineation of diverse macrophage activation programs in response to intracellular parasites and cytokines, PLoS Negl. Trop. Dis. 4 (2010) e648.
28. J.V. Lacavé-Lapalun, M. Benderitter, C. Linard, Flagellin or lipopolysaccharide treatment modified macrophage populations after colorectal radiation of rats, J. Pharmacol. Exp. Ther. 346 (2013) 75-85.
29. A. Mantovani, A. Sica, S. Sozzani, P. Allavena, A. Vecchi, M. Locati, The chemokine system in diverse forms of macrophage activation and polarization, Trends Immunol. 25 (2004) 677-686.
30. F.O. Martinez, A. Sica, A. Mantovani, M. Locati, Macrophage activation and polarization, Front. Biosci. 13 (2008) 453-461.
31. G. Zizzo, B.A. Hilliard, M. Monestier, P.L. Cohen, Efficient clearance of early apoptotic cells by humanmacrophages requiresM2c polarization and MerTK induction, J. Immunol. 189 (2012) 3508-3520.
32. G. Pinhal-Enfield, M. Ramanathan, G. Hasko, S.N. Vogel, A.L. Salzman, G.J. Boons, G.J. Boons, S.J. Leibovich, An angiogenic switch in macrophages involving synergy between Toll-like receptors 2, 4, 7, and 9 and adenosine A(2A) receptors, Am. J. Pathol. 163 (2003) 711-721.
33. C.J. Ferrante, G. Pinhal-Enfield, G. Elson, B.N. Cronstein, G. Hasko, S. Outram, S.J. Leibovich, The adenosine-dependent angiogenic switch of macrophages to an M2-like phenotype is independent of interleukin- 4 receptor alpha (IL-4Ralpha) signaling, Inflammation 36 (2013) 921-931.
34. C.A. Gleissner, I. Shaked, K.M. Little, K. Ley, CXC chemokine ligand 4 induces a unique transcriptome in monocyte-derived macrophages, J. Immunol. 184 (2010) 4810-4818.
35. C. Erbel, M. Tyka, C.M. Helmes, M. Akhavanpoor, G. Rupp, G. Domschke, F. Linden, A. Wolf, A. Doesch, F. Lasitschka, H.A. Katus, C.A. Gleissner, CXCL4-induced plaque macrophages can be specifically identified by co-expression of MMP7 + S100A8+ in vitro and in vivo, Innate Immun. 21 (2015) 255-265.
36. C.A. Gleissner, Macrophage phenotype modulation by CXCL4 in atherosclerosis, Front. Physiol. 3 (2012) 1.
37. F. De Paoli, B. Staels, G. Chinetti-Gbaguidi, Macrophage phenotypes and theirmodulation in atherosclerosis, Circ. J. 78 (2014) 1775-1781.
38. M.A. Bouhlel, B. Derudas, E. Rigamonti, R. Dievart, J. Brozek, S. Haulon, C. Zawadzki, B. Jude, G. Torpier, N.Marx, B. Staels, G. Chinetti-Gbaguidi, PPARγ activation primes humanmonocytes into alternativeM2macrophageswith anti-inflammatory properties, Cell Metab. 6 (2007) 137-143.
39. J.L. Stöger, M.J. Gijbels, S. van der Velden, M.Manca, C.M. van der Loos, E.A. Biessen, M.J. Daemen, E. Lutgens, M.P. de Winther, Distribution of macrophage polarization markers in human atherosclerosis, Atherosclerosis 225 (2012) 461-468.
40. G. Chinetti-Gbaguidi, M. Baron, M.A. Bouhlel, J. Vanhoutte, C. Copin, Y. Sebti, B. Derudas, T. Mayi, G. Bories, A. Tailleux, S. Haulon, C. Zawadzki, B. Jude, B. Staels, Human atherosclerotic plaque alternative macrophages display low cholesterol handling but high phagocytosis because of distinct activities of the PPARγ and LXRα pathways, Circ. Res. 108 (2011) 985-995.
41. S. Shaikh, J. Brittenden, R. Lahiri, P.A. Brown, F. Thies, H.M. Wilson, Macrophage subtypes in symptomatic carotid artery and femoral artery plaques, Eur. J. Vasc. Endovasc. Surg. 44 (2012) 491-497.
42. W.C. Huang, G.B. Sala-Newby, A. Susana, J.L. Johnson, A.C. Newby, Classical macrophage activation up-regulates several matrix metalloproteinases through mitogen activated protein kinases and nuclear factor-κB, PLoS One 7 (2012) e42507.
43. A.N. Orekhov, I.A. Sobenin, M.A. Gavrilin, A. Gratchev, S.Y. Kotyashova, N.G. Nikiforov, J. Kzhyshkowska, Macrophages in immunopathology of atherosclerosis: A target for diagnostics and therapy, Curr. Pharm. Des. 21 (2015) 1172-1179.
44. N.G. Nikiforov, Y.V. Bobryshev, V. Aladinsky, E.N. Borodachev, O. Gorlova, A. Temchenko, N. Pervushina, I.A. Sobenin, A.N. Orekhov, Modified atherogenic LDL induces overexpression of both pro-inflammatory cytokine TNFa and antiinflammatory chemokine CCL18. 81st Congress of the European Atherosclerosis Society, June 2-5, 2013, Lyon, France http://eas.meetingxpert.net/EAS-794/poster-61750/program.aspx Atherosclerosis 235 (Suppl. 1) (2014) e84-e85.
45. A.N. Orekhov, N. Nikiforov, A.A. Melnichenko, V.P. Karagodin, I.A. Sobenin, Expression of TNFalfa and CCL18 is increased as a result of cholesterol accumulation in macrophages, Arterioscler. Thromb. Vasc. Biol. 33 (Suppl. 5) (2013) (Abstract 553).
46. Y.V. Bobryshev, R.S. Lord, Mapping of vascular dendritic cells in atherosclerotic arteries suggests their involvement in local immune-inflammatory reactions, Cardiovasc. Res. 37 (1998) 799-810.
47. J.J. Boyle, H.A. Harrington, E. Piper, K. Elderfield, J. Stark, R.C. Landis, D.O. Haskard, Coronary intraplaque hemorrhage evokes a novel atheroprotective macrophage phenotype, Am. J. Pathol. 174 (2009) 1097-1108.
48. P. Philippidis, J.C. Mason, B.J. Evans, I. Nadra, K.M. Taylor, D.O. Haskard, R.C. Landis, Hemoglobin scavenger receptor CD163 mediates interleukin-10 release and heme oxygenase-1 synthesis: Antiinflammatory monocyte-macrophage responses in vitro, in resolving skin blisters in vivo, and after cardiopulmonary bypass surgery, Circ. Res. 94 (2004) 119-126.
49. A.V. Finn, M. Nakano, R. Polavarapu, V. Karmali, O. Saeed, X. Zhao, S. Yazdani, F. Otsuka, T. Davis, A. Habib, J. Narula, F.D. Kolodgie, R. Virmani, Hemoglobin directs macrophage differentiation and prevents foam cell formation in human atherosclerotic plaques, J. Am. Coll. Cardiol. 59 (2012) 166-177.
50. J.J. Boyle, M. Johns, J. Lo, A. Chiodini, N. Ambrose, P.C. Evans, J.C. Mason, D.O. Haskard, Heme induces heme oxygenase 1 via Nrf2: Role in the homeostatic macrophage response to intraplaque hemorrhage, Arterioscler. Thromb. Vasc. Biol. 31 (2011) 2685-2691.
51. J.J. Boyle, M. Johns, T. Kampfer, A.T. Nguyen, L. Game, D.J. Schaer, J.C. Mason, D.O. Haskard, Activating transcription factor 1 directs Mhem atheroprotective macrophages through coordinated iron handling and foam cell protection, Circ. Res. 110 (2012) 20-33.
52. J.J. Boyle, Heme and haemoglobin direct macrophage Mhem phenotype and counter foamcell formation in areas of intraplaque haemorrhage, Curr. Opin. Lipidol. 23 (2012) 453-461.
53. G. Bories, S. Colin, J. Vanhoutte, B. Derudas, C. Copin, M. Fanchon, M. Daoudi, L. Belloy, S. Haulon, C. Zawadzki, B. Jude, B. Staels, G. Chinetti-Gbaguidi, Liver X receptor (LXR) activation stimulates iron export in human alternative macrophages, Circ. Res. 113 (2013) 1196-1205.
54. A. Kadl, A.K.Meher, P.R. Sharma, M.Y. Lee, A.C. Doran, S.R. Johnstone, M.R. Elliott, F. Gruber, J. Han, W. Chen, T. Kensler, K.S. Ravichandran, B.E. Isakson, B.R. Wamhoff, N. Leitinger, Identification of a novel macrophage phenotype that develops in response to atherogenic phospholipids via Nrf2, Circ. Res. 107 (2010) 737-746.
55. C.R. Stewart, L.M. Stuart, K.Wilkinson, J.M. van Gils, J. Deng, A. Halle, K.J. Rayner, L. Boyer, R. Zhong, W.A. Frazier, A. Lacy-Hulbert, J.E. Khoury, D.T. Golenbock, K.J. Moore, CD36 ligands promote sterile inflammation through assembly of a Tolllike receptor 4 and 6 heterodimer, Nat. Immunol. 11 (2010) 155-161.
56. Y. Jiang, M. Wang, K. Huang, Z. Zhang, N. Shao, Y. Zhang, W. Wang, S. Wang, Oxidized low-density lipoprotein induces secretion of interleukin-1β by macrophages via reactive oxygen species-dependent NLRP3 inflammasome activation, Biochem. Biophys. Res. Commun. 425 (2012) 121-126.
57. F.J. Sheedy, A. Grebe, K.J. Rayner, P. Kalantari, B. Ramkhelawon, S.B. Carpenter, C.E. Becker, H.N. Ediriweera, A.E. Mullick, D.T. Golenbock, L.M. Stuart, E. Latz, K.A. Fitzgerald, K.J. Moore, CD36 coordinates NLRP3 inflammasome activation by facilitating intracellular nucleation of soluble ligands into particulate ligands in sterile inflammation, Nat. Immunol. 14 (2013) 812-820.
58. L.J. van Tits, R. Stienstra, P.L. van Lent, M.G. Netea, L.A. Joosten, A.F. Stalenhoef, Oxidized LDL enhances pro-inflammatory responses of alternatively activated M2 macrophages: A crucial role for Kruppel-like factor 2, Atherosclerosis 214 (2011) 345-349.
59. Y.S. Bae, J.H. Lee, S.H. Choi, S. Kim, F. Almazan, J.L.Witztum, Y.I.Miller, Macrophages generate reactive oxygen species in response tominimally oxidized low-density lipoprotein: Toll-like receptor 4- And spleen tyrosine kinase-dependent activation of NADPH oxidase 2, Circ. Res. 104 (2009) 210-218.
60. P. Wiesner, S.H. Choi, F. Almazan, C. Benner, W. Huang, C.J. Diehl, A. Gonen, S. Butler, J.L.Witztum, C.K. Glass, Y.I. Miller, Low doses of lipopolysaccharide and minimally oxidized low-density lipoprotein cooperatively activate macrophages via nuclear factor kappa B and activator protein-1: possible mechanism for acceleration of atherosclerosis by subclinical endotoxemia, Circ. Res. 107 (2010) 56-65.
61. K.A.Walton, X. Hsieh, N. Gharavi, S.Wang, G.Wang, M. Yeh, A.L. Cole, J.A. Berliner, Receptors involved in the oxidized 1-palmitoyl-2-arachidonoyl-sn-glycero-3- phosphorylcholine-mediated synthesis of interleukin-8. A role for Toll-like receptor 4 and a glycosylphosphatidylinositol anchored protein, J. Biol. Chem. 278 (2003) 29661-29666.
62. O.V. Oskolkova, T. Afonyushkin, B. Preinerstorfer, W. Bicker, S.E. von, E. Hainzl, S. Demyanets, G. Schabbauer, W. Lindner, A.D. Tselepis, J. Wojta, B.R. Binder, V.N. Bochkov, Oxidized phospholipids are more potent antagonists of lipopolysaccharide than inducers of inflammation, J. Immunol. 185 (2010) 7706-7712.
63. A.M. Kuhn, N. Tzieply, M.V. Schmidt, K.A. von, D. Namgaladze, M. Yamamoto, B. Brune, Antioxidant signaling via Nrf2 counteracts lipopolysaccharide-mediated inflammatory responses in foam cell macrophages, Free Radic. Biol. Med. 50 (2011) 1382-1391.
64. S. Freigang, F. Ampenberger, G. Spohn, S. Heer, A.T. Shamshiev, J. Kisielow, M. Hersberger, M. Yamamoto, M.F. Bachmann, M. Kopf, Nrf2 is essential for cholesterol crystal-induced inflammasome activation and exacerbation of atherosclerosis, Eur. J. Immunol. 41 (2011) 2040-2051.
65. K. Rajamäki, J. Lappalainen, K. Oörni, E. Välimäki, S. Matikainen, P.T. Kovanen, K.K. Eklund, Cholesterol crystals activate the NLRP3 inflammasome in human macrophages: A novel link between cholesterol metabolism and inflammation, PLoS One 5 (2010) e11765.
66. P. Duewell, H. Kono, K.J. Rayner, C.M. Sirois, G. Vladimer, F.G. Bauernfeind, G.S. Abela, L. Franchi, G. Nunez, M. Schnurr, T. Espevik, E. Lien, K.A. Fitzgerald, K.L. Rock, K.J. Moore, S.D. Wright, V. Hornung, E. Latz, NLRP3 inflammasomes are required for atherogenesis and activated by cholesterol crystals, Nature 464 (2010) 1357-1361.
67. R. Harkewicz, K. Hartvigsen, F. Almazan, E.A. Dennis, J.L. Witztum, Y.I. Miller, Cholesteryl ester hydroperoxides are biologically active components of minimally oxidized low density lipoprotein, J. Biol. Chem. 283 (2008) 10241-10251.
68. Z. Huang, W. Li, R.Wang, F. Zhang, Y. Chi, D.Wang, Z. Liu, Y. Zhang, E.Matsuura, Q. Liu, 7-ketocholesteryl-9-carboxynonanoate induced nuclear factor-kappa B activation in J774A.1 macrophages, Life Sci. 87 (2010) 651-657.
69. J. Huber, H. Boechzelt, B. Karten, M. Surboeck, V.N. Bochkov, B.R. Binder, W. Sattler, N. Leitinger, Oxidized cholesteryl linoleates stimulate endothelial cells to bind monocytes via the extracellular signal-regulated kinase 1/2 pathway, Arterioscler. Thromb. Vasc. Biol. 22 (2002) 581-586.
70. I. Jedidi, M. Couturier, P. Thérond, M. Gardès-Albert, A. Legrand, R. Barouki, D. Bonnefont-Rousselot, M. Aggerbeck, Cholesteryl ester hydroperoxides increase macrophage CD36 gene expression via PPARalpha, Biochem. Biophys. Res. Commun. 351 (2006) 733-738.
71. N.S. Kar, M.Z. Ashraf, M. Valiyaveettil, E.A. Podrez, Mapping and characterization of the binding site for specific oxidized phospholipids and oxidized low density lipoprotein of scavenger receptor CD36, J. Biol. Chem. 283 (2008) 8765-8771.
72. V.P. Yakubenko, A. Bhattacharjee, E. Pluskota, M.K. Cathcart, αMβ2 integrin activation prevents alternative activation of human and murine macrophages and impedes foam cell formation, Circ. Res. 108 (2011) 544-554.
73. N. Shibata, C.K. Glass, Macrophages, oxysterols and atherosclerosis, Circ. J. 74 (2010) 2045-2051.
74. T. Chen, Z. Huang, L.Wang, Y.Wang, F.Wu, S. Meng, C.Wang, MicroRNA-125a-5p partly regulates the inflammatory response, lipid uptake, and ORP9 expression in oxLDL-stimulated monocyte/macrophages, Cardiovasc. Res. 83 (2009) 131-139.
75. G. Leonarduzzi, P. Gamba, B. Sottero, A. Kadl, F. Robbesyn, R.A. Calogero, F. Biasi, E. Chiarpotto, N. Leitinger, A. Sevanian, G. Poli, Oxysterol-induced up-regulation of MCP-1 expression and synthesis in macrophage cells, Free Radic. Biol. Med. 39 (2005) 1152-1161.
76. G. Leonarduzzi, S. Gargiulo, P. Gamba, M.G. Perrelli, I. Castellano, A. Sapino, B. Sottero, G. Poli, Molecular signaling operated by a diet-compatible mixture of oxysterols in up-regulating CD36 receptor in CD68 positive cells, Mol. Nutr. Food Res. 54 (Suppl. 1) (2010) S31-S41.
77. S. Adamson, N. Leitinger, Phenotypic modulation of macrophages in response to plaque lipids, Curr. Opin. Lipidol. 22 (2011) 335-342.
78. K. Lähdesmäki, R. Plihtari, P. Soininen, E. Hurt-Camejo, M. Ala-Korpela, K. Oörni, P.T. Kovanen, Phospholipase A(2)-modified LDL particles retain the generated hydrolytic products and are more atherogenic at acidic pH, Atherosclerosis 207 (2009) 352-359.
79. B.B. Boyanovsky, X. Li, P. Shridas, M. Sunkara, A.J. Morris, N.R. Webb, Bioactive products generated by group V sPLA(2) hydrolysis of LDL activate macrophages to secrete pro-inflammatory cytokines, Cytokine 50 (2010) 50-57.
80. H. Obinata, T. Hattori, S. Nakane, K. Tatei, T. Izumi, Identification of 9- hydroxyoctadecadienoic acid and other oxidized free fatty acids as ligands of the G protein-coupled receptor G2A, J. Biol. Chem. 280 (2005) 40676-40683.
81. C. Peter, M. Waibel, C.G. Radu, L.V. Yang, O.N. Witte, K. Schulze-Osthoff, S. Wesselborg, K. Lauber, Migration to apoptotic "find-me" signals is mediated via the phagocyte receptor G2A, J. Biol. Chem. 283 (2008) 5296-5305.
82. Z.Weng, A.C. Fluckiger, S. Nisitani, M.I.Wahl, L.Q. Le, C.A. Hunter, A.A. Fernal, M.M. Le Beau, O.N.Witte, A DNA damage and stress inducible G protein-coupled receptor blocks cells in G2/M, Proc. Natl. Acad. Sci. U. S. A. 95 (1998) 12334-12339.
83. B.W. Parks, A.J. Lusis, J.H. Kabarowski, Loss of the lysophosphatidylcholine effector, G2A, ameliorates aortic atherosclerosis in low-density lipoprotein receptor knockout mice, Arterioscler. Thromb. Vasc. Biol. 26 (2006) 2703-2709.
84. D.T. Bolick, M.D. Skaflen, L.E. Johnson, S.C. Kwon, D. Howatt, A. Daugherty, K.S. Ravichandran, C.C. Hedrick, G2A deficiency in mice promotes macrophage activation and atherosclerosis, Circ. Res. 104 (2009) 318-327.
85. H. Shi, M.V. Kokoeva, K. Inouye, I. Tzameli, H. Yin, J.S. Flier, TLR4 links innate immunity and fatty acid-induced insulin resistance, J. Clin. Invest. 116 (2006) 3015-3025.
86. M.R. Dasu, I. Jialal, Free fatty acids in the presence of high glucose amplify monocyte inflammation via Toll-like receptors, Am. J. Physiol. Endocrinol. Metab. 300 (2011) E145-E154.
87. J. Ishiyama, R. Taguchi, A. Yamamoto, K. Murakami, Palmitic acid enhances lectinlike oxidized LDL receptor (LOX-1) expression and promotes uptake of oxidized LDL in macrophage cells, Atherosclerosis 209 (2010) 118-124.
88. S. McClelland, C. Cox, R. O'Connor, M. de Gaetano, C. McCarthy, L. Cryan, D. Fitzgerald, O. Belton, Conjugated linoleic acid suppresses the migratory and inflammatory phenotype of the monocyte/macrophage cell, Atherosclerosis 211 (2010) 96-102.
89. N.K. Khoo, B.A. Freeman, Electrophilic nitro-fatty acids: Anti-inflammatory mediators in the vascular compartment, Curr. Opin. Pharmacol. 10 (2010) 179-184.
90. F.J. Schopfer, M.P. Cole, A.L. Groeger, C.S. Chen, N.K. Khoo, S.R. Woodcock, F. Golin- Bisello, U.N.Motanya, Y. Li, J. Zhang, M.T. Garcia-Barrio, T.K. Rudolph, V. Rudolph, G. Bonacci, P.R. Baker, H.E. Xu, C.I. Batthyany, Y.E. Chen, T.M. Hallis, B.A. Freeman, Covalent peroxisome proliferator activated receptor gamma adduction by nitro-fatty acids: selective ligand activity and anti-diabetic signaling actions, J. Biol. Chem. 285 (2010) 12321-12333.
91. E. Kansanen, G. Bonacci, F.J. Schopfer, S.M. Kuosmanen, K.I. Tong, H. Leinonen, S.R. Woodcock, M. Yamamoto, C. Carlberg, S. Yla-Herttuala, B.A. Freeman, A.L. Levonen, Electrophilic nitro-fatty acids activate NRF2 by a KEAP1 cysteine 151-independent mechanism, J. Biol. Chem. 286 (2011) 14019-14027.
92. T.K. Rudolph, V. Rudolph, M.M. Edreira, M.P. Cole, G. Bonacci, F.J. Schopfer, S.R. Woodcock, A. Franek, M. Pekarova, N.K. Khoo, A.H. Hasty, S. Baldus, B.A. Freeman, Nitro-fatty acids reduce atherosclerosis in apolipoprotein E-deficient mice, Arterioscler. Thromb. Vasc. Biol. 30 (2010) 938-945.
93. G. Bonacci, F.J. Schopfer, C.I. Batthyany, T.K. Rudolph, V. Rudolph, N.K. Khoo, E.E. Kelley, B.A. Freeman, Electrophilic fatty acids regulatematrixmetalloproteinase activity and expression, J. Biol. Chem. 286 (2011) 16074-16081.
94. S. Li, Y. Sun, C.P. Liang, E.B. Thorp, S. Han, A.W. Jehle, V. Saraswathi, B. Pridgen, J.E. Kanter, R. Li, C.L. Welch, A.H. Hasty, K.E. Bornfeldt, J.L. Breslow, I. Tabas, A.R. Tall, Defective phagocytosis of apoptotic cells bymacrophages in atherosclerotic lesions of ob/ob mice and reversal by a fish oil diet, Circ. Res. 105 (2009) 1072-1082.
95. A.L. Groeger, C. Cipollina, M.P. Cole, S.R. Woodcock, G. Bonacci, T.K. Rudolph, V. Rudolph, B.A. Freeman, F.J. Schopfer, Cyclooxygenase-2 generates antiinflammatory mediators from omega-3 fatty acids, Nat. Chem. Biol. 6 (2010) 433-441.
96. A.J. Merched, K. Ko, K.H. Gotlinger, C.N. Serhan, L. Chan, Atherosclerosis: Evidence for impairment of resolution of vascular inflammation governed by specific lipid mediators, FASEB J. 22 (2008) 3595-3606.
97. V. Grover, R. Malhotra, A. Kapoor, J. Singh, S. Sachdeva, Proresolution mediators and receptors: novel drug targets for enhancing pharmacological armamentarium against periodontal inflammation, Infect. Disord. Drug Targets 13 (2013) 75-84.
98. D.J. Rader, Molecular regulation of HDL metabolism and function: Implications for novel therapies, J. Clin. Invest. 116 (2006) 3090-3100.
99. J.E. Feig, J.X. Rong, R. Shamir, M. Sanson, Y. Vengrenyuk, J. Liu, K. Rayner, K. Moore, M. Garabedian, E.A. Fisher, HDL promotes rapid atherosclerosis regression in mice and alters inflammatory properties of plaque monocyte-derived cells, Proc. Natl. Acad. Sci. U. S. A. 108 (2011) 7166-7171.
100. M. Sanson, E. Distel, E.A. Fisher, HDL induces the expression of theM2macrophage markers arginase 1 and Fizz-1 in a STAT6-dependent process, PLoS One 8 (2013) e74676.
101. M. Mori, Regulation of nitric oxide synthesis and apoptosis by arginase and arginine recycling, J. Nutr. 137 (Suppl. 2) (2007) 1616S-1620S.
102. H. Chen, B.A. Jacobson, L. Mason, S.F. Wolf, M.R. Bowman, FIZZ1 potentiates the carbachol-induced tracheal smooth muscle contraction, Eur. Respir. J. 36 (2010) 1165-1173.
103. J.I. Odegaard, R.R. Ricardo-Gonzalez, M.H. Goforth, C.R. Morel, V. Subramanian, L. Mukundan, A.R. Eagle, D. Vats, F. Brombacher, A.W. Ferrante, A. Chawla, Macrophage-specific ppargamma controls alternative activation and improves insulin resistance, Nature 447 (2007) 1116-1120.
104. J.I. Odegaard, R.R. Ricardo-Gonzalez, A. Red Eagle, D. Vats, C.R. Morel, M.H. Goforth, V. Subramanian, L. Mukundan, A.W. Ferrante, A. Chawla, Alternative M2 activation of Kupffer cells by ppardelta ameliorates obesity-induced insulin resistance, Cell Metab. 7960 (2008) 496-507.
105. K. Kang, S.M. Reilly, V. Karabacak, M.R. Gangl, K. Fitzgerald, B. Hatano, C.H. Lee, Adipocyte-derived Th2 cytokines andmyeloid PPARdelta regulate macrophage polarization and insulin sensitivity, Cell Metab. 7 (2008) 485-495.
106. N.J. Spann, L.X. Garmire, J.G. McDonald, D.S. Myers, S.B. Milne, N. Shibata, D. Reichart, J.N. Fox, I. Shaked, D. Heudobler, C.R. Raetz, E.W. Wang, S.L. Kelly, M.C. Sullards, R.C. Murphy, A.H. Merrill Jr., H.A. Brown, E.A. Dennis, A.C. Li, K. Ley, S. Tsimikas, E. Fahy, S. Subramaniam, O. Quehenberger, D.W. Russell, C.K. Glass, Regulated accumulation of desmosterol integrates macrophage lipid metabolism and inflammatory responses, Cell 151 (2012) 138-152.
107. P. Tontonoz, D.J. Mangelsdorf, Liver X receptor signaling pathways in cardiovascular disease, Mol. Endocrinol. 17 (2003) 985-993.
108. S.B. Joseph, E. McKilligin, L. Pei, M.A. Watson, A.R. Collins, B.A. Laffitte, M. Chen, G. Noh, J. Goodman, G.N. Hagger, J. Tran, T.K. Tippin, X. Wang, A.J. Lusis, W.A. Hsueh, R.E. Law, J.L. Collins, T.M.Willson, P. Tontonoz, Synthetic LXR ligand inhibits the development of atherosclerosis in mice, Proc. Natl. Acad. Sci. U. S. A. 99 (2002) 7604-7609.
109. N. Levin, E.D. Bischoff, C.L. Daige, D. Thomas, C.T. Vu, R.A. Heyman, R.K. Tangirala, I.G. Schulman, Macrophage liver x receptor is required for antiatherogenic activity of LXR agonists, Arterioscler. Thromb. Vasc. Biol. 25 (2005) 135-142.
110. E.D. Bischoff, C.L. Daige, M. Petrowski, H. Dedman, J. Pattison, J. Juliano, A.C. Li, I.G. Schulman, Nonredundant roles for LXRalpha and LXRbeta in atherosclerosis susceptibility in low density lipoprotein receptor knockout mice, J. Lipid Res. 51 (2010) 900-906.
111. L. Ma, F. Dong, M. Zaid, A. Kumar, X. Zha, ABCA1 protein enhances Toll-like receptor 4 (TLR4)-stimulated interleukin-10 (IL-10) secretion through protein kinase a (PKA) activation, J. Biol. Chem. 287 (2012) 40502-40512.
112. B. Pourcet, J.E. Feig, Y. Vengrenyuk, A.J. Hobbs, D. Kepka-Lenhart, M.J. Garabedian, S.M. Morris Jr., E.A. Fisher, I. Pineda-Torra, LXRalpha regulates macrophage arginase 1 through PU.1 and interferon regulatory factor 8, Circ. Res. 109 (2011) 492-501.
113. S. Ghisletti, W. Huang, S. Ogawa, G. Pascual, M.E. Lin, T.M.Willson, M.G. Rosenfeld, C.K. Glass, Parallel sumoylation-dependent pathways mediate gene- And signalspecific transrepression by LXRs and PPARgamma, Mol. Cell 25 (2007) 57-70.
114. S.B. Joseph, M.N. Bradley, A. Castrillo, K.W. Bruhn, P.A. Mak, L. Pei, J. Hogenesch, R.M. O'Connell, G. Cheng, E. Saez, J.F. Miller, P. Tontonoz, LXR-dependent gene expression is important for macrophage survival and the innate immune response, Cell 119 (2004) 299-309.
115. Y. Li, C. Bolten, B.G. Bhat, J. Woodring-Dietz, S. Li, S.K. Prayaga, C. Xia, D.S. Lala, Induction of human liver X receptor alpha gene expression via an autoregulatory loop mechanism, Mol. Endocrinol. 16 (2002) 506-514.
116. V. Ribas, B.G. Drew, J.A. Le, T. Soleymani, P. Daraei, D. Sitz, L. Mohammad, D.C. Henstridge, M.A. Febbraio, S.C. Hewitt, K.S. Korach, S.J. Bensinger, A.L. Hevener, Myeloid-specific estrogen receptor alpha deficiency impairs metabolic homeostasis and accelerates atherosclerotic lesion development, Proc. Natl. Acad. Sci. U. S. A. 108 (2011) 16457-16462.
117. J. Sonoda, J. Laganiere, I.R. Mehl, G.D. Barish, L.W. Chong, X. Li, I.E. Scheffler, D.C. Mock, A.R. Bataille, F. Robert, C.H. Lee, V. Giguere, R.M. Evans, Nuclear receptor ERRalpha and coactivator PGC-1 beta are effectors of IFN-gamma-induced host defense, Genes Dev. 21 (2007) 1909-1920.
118. M.W. Feinberg, Z. Cao, A.K. Wara, M.A. Lebedeva, S. Senbanerjee, M.K. Jain, Kruppel-like factor 4 is a mediator of proinflammatory signaling in macrophages, J. Biol. Chem. 280 (2005) 38247-38258.
119. T. Yang, C. Chen, B. Zhang, H. Huang, G. Wu, J.Wen, J. Liu, Induction of Krüppel-like factor 4 by high-density lipoproteins promotes the expression of scavenger receptor class B type I, FEBS J. 277 (2010) 3780-3788.
120. F. Lovren, Y. Pan, A. Quan, K.K. Singh, P.C. Shukla, N. Gupta, B.M. Steer, A.J. Ingram, M. Gupta, M. Al-Omran, H. Teoh, P.A. Marsden, S. Verma, MicroRNA-145 targeted therapy reduces atherosclerosis, Circulation 126 (Suppl. 1) (2012) S81-S90.
121. D. Date, R. Das, G. Narla, D.I. Simon, M.K. Jain, G.H. Mahabeleshwar, Kruppel-like transcription factor 6 regulates inflammatory macrophage polarization, J. Biol. Chem. 289 (2014) 10318-10329.
122. R. Urtasun, F.J. Cubero, N. Nieto, Oxidative stress modulates KLF6Full and its splice variants, Alcohol. Clin. Exp. Res. 36 (2012) 1851-1862.
123. N. Dhaouadi, J.Y. Li, P. Feugier, M.P. Gustin, H. Dab, K. Kacem, G. Bricca, C. Cerutti, Computational identification of potential transcriptional regulators of TGF-ß1 in human atherosclerotic arteries, Genomics 103 (2014) 357-370.
124. R.N. Hanna, L.M. Carlin, H.G. Hubbeling, D. Nackiewicz, A.M. Green, J.A. Punt, F. Geissmann, C.C. Hedrick, The transcription factor NR4A1 (Nur77) controls bone marrow differentiation and the survival of Ly6C- monocytes, Nat. Immunol. 12 (2011) 778-785.
125. A.A. Hamers, M. Vos, F. Rassam, G. Marinković, K. Kurakula, P.J. van Gorp, M.P. de Winther, M.J. Gijbels, V. de Waard, C.J. de Vries, Bone marrow-specific deficiency of nuclear receptor Nur77 enhances atherosclerosis, Circ. Res. 110 (2012) 428-438.
126. R.N. Hanna, I. Shaked, H.G. Hubbeling, J.A. Punt, R.Wu, E. Herrley, C. Zaugg, H. Pei, F. Geissmann, K. Ley, C.C. Hedrick, NR4A1 (Nur77) deletion polarizes macrophages toward an inflammatory phenotype and increases atherosclerosis, Circ. Res. 110 (2012) 416-427.
127. L.C. Chao, E. Soto, C. Hong, A. Ito, L. Pei, A. Chawla, O.M. Conneely, R.K. Tangirala, R.M. Evans, P. Tontonoz, Bone marrow NR4A expression is not a dominant factor in the development of atherosclerosis or macrophage polarization in mice, J. Lipid Res. 54 (2013) 806-815.
128. P.I. Bonta, C.M. van Tiel, M. Vos, T.W. Pols, J.V. van Thienen, V. Ferreira, E.K. Arkenbout, J. Seppen, C.A. Spek, T. van der Poll, H. Pannekoek, C.J. de Vries, Nuclear receptors Nur77, Nurr1, and NOR-1 expressed in atherosclerotic lesion macrophages reduce lipid loading and inflammatory responses, Arterioscler. Thromb. Vasc. Biol. 26 (2006) 2288-2294.
129. J.P. McMorrow, E.P. Murphy, Inflammation: A role for NR4A orphan nuclear receptors? Biochem. Soc. Trans. 39 (2011) 688-693.